Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Operating Margin (2019 - 2025)

Biodesix (BDSX) has disclosed Operating Margin for 7 consecutive years, with 6.84% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 2571.0% year-over-year to 6.84%, compared with a TTM value of 31.5% through Dec 2025, up 1687.0%, and an annual FY2025 reading of 31.5%, up 1687.0% over the prior year.
  • Operating Margin was 6.84% for Q4 2025 at Biodesix, up from 32.39% in the prior quarter.
  • Across five years, Operating Margin topped out at 6.84% in Q4 2025 and bottomed at 220.85% in Q1 2022.
  • Average Operating Margin over 5 years is 87.47%, with a median of 63.77% recorded in 2023.
  • The sharpest move saw Operating Margin surged 14593bps in 2021, then crashed -20150bps in 2022.
  • Year by year, Operating Margin stood at 161.67% in 2021, then rose by 11bps to 144.58% in 2022, then soared by 68bps to 46.84% in 2023, then surged by 31bps to 32.55% in 2024, then skyrocketed by 79bps to 6.84% in 2025.
  • Business Quant data shows Operating Margin for BDSX at 6.84% in Q4 2025, 32.39% in Q3 2025, and 48.55% in Q2 2025.